Search

Your search keyword '"Sardone, Andrea"' showing total 15 results
Start Over Author "Sardone, Andrea"
15 results on '"Sardone, Andrea"'

1. Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study

Author

Bruno, Francesco, de Filippo, Ovidio, Sardone, Andrea, Capranzano, Piera, Conrotto, Federico, Sheiban, Imad, Giacobbe, Federico, Laudani, Claudio, Burzotta, Francesco, Saia, Francesco, Escaned, Javier, Raposeiras Roubin, Sergio, Mancone, Massimo, Templin, Christian, Candreva, Alessandro, Trabattoni, Daniela, Wanha, Wojciech, Stefanini, Giulio, Chieffo, Alaide, Cortese, Bernardo, Casella, Gianni, Wojakowski, Wojciech, Colombo, Francesco, De Ferrari, Gaetano Maria, Boccuzzi, Giacomo, D'Ascenzo, Fabrizio, and Iannaccone, Mario

Published
2024
Full Text
View/download PDF

2. Percutaneous coronary interventions for aneurysmatic right coronary artery in acute coronary syndrome: RIGHTMARE registry outcomes

Author

Piedimonte, Giulio, Cerrato, Enrico, Rolfo, Cristina, Nunez Gil, Ivan J., Azzalini, Lorenzo, Mangione, Riccardo, Maiellaro, Francesco, Boi, Alberto, Riganelli, Donovan, Sardone, Andrea, Bruno, Francesco, Scudiero, Fernando, Vizzari, Giampiero, Carciotto, Gabriele, Calderone, Dario, Borgi, Marco, Cancro, Francesco Paolo, Sanchez, Ivan, Leoncini, Massimo, Sagazio, Emanuele, Colombo, Francesco, Rosso, Gabriele, Chechi, Tania, Zecchino, Simone, Pavani, Marco, Franzè, Alfonso, Zanda, Greca, Bosco, Manuel, Hernandez, Jose Maria De La Torre, Micari, Antonio, Galasso, Gennaro, Versaci, Francesco, Tamburino, Corrado, Patti, Giuseppe, La Manna, Alessio, Tomassini, Francesco, and Varbella, Ferdinando

Published
2024
Full Text
View/download PDF

6. Impact of Successful Chronic Coronary Total Occlusion Recanalization on Recurrence of Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Recipients for Ischemic Cardiomyopathy (VACTO PCI Study)

Author

Iannaccone, Mario, primary, Nombela-Franco, Luis, additional, Gallone, Guglielmo, additional, Annone, Umberto, additional, Di Marco, Andrea, additional, Giannini, Francesco, additional, Ayoub, Mohammed, additional, Sardone, Andrea, additional, Amat-Santos, Ignacio, additional, Fernandez-Lozano, Ignacio, additional, Barbero, Umberto, additional, Dusi, Veronica, additional, Toselli, Marco, additional, Petretta, Andrea, additional, de Salvia, Alberto, additional, Boccuzzi, Giacomo, additional, Colangelo, Salvatore, additional, Anguera, Ignasi, additional, D'Ascenzo, Fabrizio, additional, Colombo, Antonio, additional, De Ferrari, Gaetano Maria, additional, Escaned, Javier, additional, Garbo, Roberto, additional, and Mashayekhi, Kambis, additional

Published
2022
Full Text
View/download PDF

9. TCT-238 Real-World Experience With the New Watchman FLX Device: Data From Two High-Volume Sicilian Centers: The FLX-IEST Registry

Author

Vizzari, Giampiero, primary, Contarini, Marco, additional, Mazzone, Paolo, additional, Sardone, Andrea, additional, Laterra, Giulia, additional, Frazzetto, Marco Giuseppe, additional, Sanfilippo, Maria, additional, Sacchetta, Giorgio, additional, Tamburino, Corrado, additional, Micari, Antonio, additional, and Grasso, Carmelo, additional

Published
2021
Full Text
View/download PDF

10. Impact of Post-Procedural Change in Left Ventricle Systolic Function on Survival after Percutaneous Edge-to-Edge Mitral Valve Repair

Author

Hagnäs, Magnus J., primary, Grasso, Carmelo, additional, Di Salvo, Maria Elena, additional, Caggegi, Anna, additional, Barbanti, Marco, additional, Scandura, Salvatore, additional, Milici, Annalisa, additional, Motta, Gessica, additional, Bentivegna, Agnese, additional, Sardone, Andrea, additional, Capodicasa, Luigi, additional, Giuffrida, Angelo, additional, Biancari, Fausto, additional, Mäkikallio, Timo, additional, Capodanno, Davide, additional, and Tamburino, Corrado, additional

Published
2021
Full Text
View/download PDF

11. Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems.

Author

Capranzano, Piera, primary, Francaviglia, Bruno, additional, Sardone, Andrea, additional, Agnello, Federica, additional, Valenti, Noemi, additional, Frazzetto, Marco, additional, Legnazzi, Marco, additional, Occhipinti, Giovanni, additional, Scalia, Lorenzo, additional, Calvi, Valeria, additional, Capodanno, Davide, additional, and Tamburino, Corrado, additional

Published
2021
Full Text
View/download PDF

12. Effect of post‐procedural evidence‐based therapy on 2‐year prognosis after transcatheter mitral valve repair

Author

Hagnäs, Magnus J., primary, Grasso, Carmelo, additional, Di Salvo, Maria Elena, additional, Sardone, Andrea, additional, Rapisarda, Paola, additional, Pelliccia, Matteo, additional, Dipasquale, Francesco, additional, Castania, Giuseppe, additional, Mangiafico, Sarah, additional, Capranzano, Piera, additional, Barbanti, Marco, additional, Denaro, Alessandro, additional, Scandura, Salvatore, additional, Mäkikallio, Timo, additional, Capodanno, Davide, additional, and Tamburino, Corrado, additional

Published
2020
Full Text
View/download PDF

14. Effect of post‐procedural evidence‐based therapy on 2‐year prognosis after transcatheter mitral valve repair.

Author

Hagnäs, Magnus J., Grasso, Carmelo, Di Salvo, Maria Elena, Sardone, Andrea, Rapisarda, Paola, Pelliccia, Matteo, Dipasquale, Francesco, Castania, Giuseppe, Mangiafico, Sarah, Capranzano, Piera, Barbanti, Marco, Denaro, Alessandro, Scandura, Salvatore, Mäkikallio, Timo, Capodanno, Davide, and Tamburino, Corrado

Subjects
MITRAL valve insufficiency, MITRAL valve, PROGNOSIS
Abstract

Guidelines recommend the use of neurohormonal antagonists for all patients with heart failure and mitral regurgitation (MR) as an initial treatment strategy.1,2 Patients with symptoms despite maximally tolerated neurohormonal antagonist treatment, evidence-based therapy (EBT), and moderate-to-severe MR who are surgery-ineligible may undergo transcatheter mitral valve repair with the MitraClip (Abbott Vascular, Abbott Park, IL, USA) system. Patients undergoing the MitraClip procedure for secondary MR with EBT are at lower risk of death compared to patients without EBT. In the era of surgical and transcatheter treatment options, the importance of medications may be neglected when severe MR is present in a patient with heart failure. [Extracted from the article]

Published
2021
Full Text
View/download PDF

15. [Percutaneous treatment of intermediate- and high-risk pulmonary embolism: two case reports].

Author

Sardone A, Iannaccone M, Savio D, Colombo F, Di Maggio L, Colangelo S, Franchin L, and Boccuzzi GG

Subjects
Humans, Treatment Outcome, Pulmonary Embolism drug therapy, Thrombolytic Therapy
Abstract

Pulmonary embolism is the third most common cause of cardiovascular emergency. Risk stratification is crucial in the clinical and therapeutic management of these patients. The latest European guidelines introduced a new classification based on short-term mortality risk stratification, dividing patients into four categories (high, intermediate-high, intermediate-low and low risk). Despite the limited evidence in this field, the percutaneous treatment of pulmonary embolism represents an option of interest; however, correct patient selection and device choice should be better investigated. In this article, we present two case reports of patients with intermediate-high-risk and high-risk pulmonary embolism treated with the EkoSonic Endovascular System (EKOS Corp., Bothell, WA, USA) and the FlowTriever System (Inari Medical, Irvine, CA, USA), respectively.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results